TB treatments are notoriously hard to adhere to, and a shorter regimen is here to offer a breakthrough. People at high risk of developing tuberculosis will soon access a once-weekly pill that prevents TB bacteria from developing into a contagious case. The rollout continues in five AU Member States: Ethiopia, Ghana, Kenya, Mozambique, and Zimbabwe. The short-course preventative treatment will reduce the pill burden from nine to three pills a week for adults. The new fixed-dose combination (FDC) tuberculosis (TB) treatment aims to improve the ease of treatment adherence, increase the availability of treatments, and get the world back on track to achieve the goal of ending TB by 2030.